KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EBT (2018 - 2025)

Historic EBT for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$30.3 million.

  • Twist Bioscience's EBT rose 394.64% to -$30.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$75.7 million, marking a year-over-year increase of 6152.61%. This contributed to the annual value of -$77.0 million for FY2025, which is 6303.38% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's EBT is -$30.3 million, which was up 394.64% from -$26.9 million recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's EBT peaked at $20.6 million during Q2 2025, and registered a low of -$85.4 million during Q2 2024.
  • Its 5-year average for EBT is -$43.4 million, with a median of -$42.7 million in 2021.
  • In the last 5 years, Twist Bioscience's EBT crashed by 7035.37% in 2021 and then skyrocketed by 12410.52% in 2025.
  • Twist Bioscience's EBT (Quarter) stood at -$56.0 million in 2021, then rose by 25.41% to -$41.7 million in 2022, then fell by 2.73% to -$42.9 million in 2023, then increased by 26.56% to -$31.5 million in 2024, then grew by 3.95% to -$30.3 million in 2025.
  • Its EBT stands at -$30.3 million for Q4 2025, versus -$26.9 million for Q3 2025 and $20.6 million for Q2 2025.